Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1984 Dec;11(4):352–362.

Action of Amiodarone Over the Extension and Reversibility of Experimental Myocardial Infarction in Pigs

Carlos B Alvarez 1, Alfredo Castelli 1, Ernesto Grassi 1, David Celener 1, Mauricio Rapapport 1, José Martín 1
PMCID: PMC351709  PMID: 15226875

Abstract

The purpose of the present work is to evaluate the action of a benzofuran derivative, Amiodarone, on an experimental acute infarction model. Six pigs were intravenously administered 1 mg/kg Amiodarone (A) 20 minutes before inducing ischemia (I) by occlusion of the anterior descending coronary artery, which was maintained for 90 minutes. A similar dose level was repeated 20 minutes before ligation release (R). Similarly, another six animals received a placebo and formed the Control Group (C). The extent of myocardial injury was assessed by summations of ST segments (Σ ST) and R (Σ R) and Q (Σ Q) waves of electrocardiographic epicardial mappings, as well as by serum levels for SGOT and LDH. Systemic blood pressure, pulmonary pressure, right atrial pressure, systemic resistance and cardiac output were also controlled.

Two hundred and ten minutes after R, the animal was sacrificed for the purpose of carrying out morphological and histochemical studies. No significant differences were observed in the blood pressure of either group. During I, systemic resistance values suffered a drop in the Amiodarone Group A, whereas they increased in both groups after reperfusion. Pulmonary pressure was higher in Group A. Cardiac output showed a similar behavior in both groups up to R, when it significantly decreased in animals receiving Amiodarone. The Σ ST and the Σ Q were higher in the Control Group C, whereas the Σ R was higher in Group A. The SGOT and LDH levels were higher during R in Group C. Histochemistry showed a higher activity for SDH and LDH in treated animals.

Due to its action on afterload, its contractility and its direct myocardial action, Amiodarone limited the extent of necrosis and increased the recoverable amount of myocardium.

Full text

PDF
352

Images in this article

354Image
on p.354
354Image
on p.354
361Image
on p.361
361Image
on p.361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broekhuysen J., Clinet M., Delisee C. Action of amiodarone on guinea pig heart sodium and potassium activated adenosine triphosphatase. Comparison with ouabain. Biochem Pharmacol. 1972 Nov 15;21(22):2951–2960. doi: 10.1016/0006-2952(72)90188-8. [DOI] [PubMed] [Google Scholar]
  2. Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed] [Google Scholar]
  3. Clinet M., Broekhuysen J. Action of amiodarone on rabbit muscle calcium-dependent adenosine triphosphatase. Biochem Pharmacol. 1972 Nov 15;21(22):2961–2965. doi: 10.1016/0006-2952(72)90189-x. [DOI] [PubMed] [Google Scholar]
  4. Cox J. L., McLaughlin V. W., Flowers N. C., Horan L. G. The ischemic zone surrounding acute myocardial infarction. Its morphology as detected by dehydrogenase staining. Am Heart J. 1968 Nov;76(5):650–659. doi: 10.1016/0002-8703(68)90164-6. [DOI] [PubMed] [Google Scholar]
  5. Côté P., Bourassa M. G., Delaye J., Janin A., Froment R., David P. Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation. 1979 Jun;59(6):1165–1172. doi: 10.1161/01.cir.59.6.1165. [DOI] [PubMed] [Google Scholar]
  6. DeBoer L. W., Nosta J. J., Kloner R. A., Braunwald E. Studies of amiodarone during experimental myocardial infarction: beneficial effects on hemodynamics and infarct size. Circulation. 1982 Mar;65(3):508–512. doi: 10.1161/01.cir.65.3.508. [DOI] [PubMed] [Google Scholar]
  7. FARBER E., STERNBERG W. H., DUNLAP C. E. Histochemical localization of specific oxidative enzymes. I. Tetrazolium stains for diphosphopyridine nucleotide diaphorase and triphosphopyridine nucleotide diaphorase. J Histochem Cytochem. 1956 May;4(3):254–265. doi: 10.1177/4.3.254. [DOI] [PubMed] [Google Scholar]
  8. Henry P. D., Shuchleib R., Borda L. J., Roberts R., Williamson J. R., Sobel B. E. Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res. 1978 Sep;43(3):372–380. doi: 10.1161/01.res.43.3.372. [DOI] [PubMed] [Google Scholar]
  9. Henry P. D., Shuchleib R., Clark R. E., Perez J. E. Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. Am J Cardiol. 1979 Oct 22;44(5):817–824. doi: 10.1016/0002-9149(79)90203-0. [DOI] [PubMed] [Google Scholar]
  10. McCabe M., Maple A. J., Jones G. R. Variations in dehydrogenase and neotetrazolium reductase (diaphorase) activities in various buffers studied quantitatively in frozen sections. J Histochem Cytochem. 1965 Sep-Oct;13(7):541–546. doi: 10.1177/13.7.541. [DOI] [PubMed] [Google Scholar]
  11. Ourbak P., Rocher R., Aziza J. P., Manin J. P., Vagner D., Leclerc M., Maurice P. Effets hémodynamiques de l'injection intra-veineuse de chlorhydrate d'amiodarone chez le sujet normal et le coronarien. Arch Mal Coeur Vaiss. 1976 Mar;69(3):293–298. [PubMed] [Google Scholar]
  12. Rosenbaum M. B., Chiale P. A., Ryba D., Elizari M. V. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol. 1974 Aug;34(2):215–223. doi: 10.1016/0002-9149(74)90200-8. [DOI] [PubMed] [Google Scholar]
  13. Singh B. N., Jewitt D. E., Downey J. M., Kirk E. S., Sonnenblick E. H. Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. Clin Exp Pharmacol Physiol. 1976 Sep-Oct;3(5):427–442. doi: 10.1111/j.1440-1681.1976.tb00620.x. [DOI] [PubMed] [Google Scholar]
  14. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wellens H. J., Lie K. I., Bär F. W., Wesdorp J. C., Dohmen H. J., Düren D. R., Durrer D. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1976 Aug;38(2):189–194. doi: 10.1016/0002-9149(76)90148-x. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES